Encompass Health Corporation announced that it has received the required consents from holders of its 4.500% Senior Notes due 2028, 4.750% Senior Notes due 2030 and 4.625% Senior Notes due 2031 to certain proposed amendments described in the Consent Solicitation Statement, dated December 9, 2021 to the indenture governing the Notes. The solicitation of consents from the holders of the Notes expired at 5:00 p.m., New York City time on January 24, 2022. On January 24, 2022, the Company, its subsidiaries party to the Indenture as guarantors, and the indenture trustee executed a supplemental indenture in respect of the Notes in accordance with the Statement.

The Supplemental Indenture will become effective upon its execution at the Consent Effective Time and payment of the First Consent Payment and is binding on all holders of the Notes, even those who did not deliver a consent at or prior to the Expiration Date, but the Proposed Amendments will become operative only if the Company makes the Second Consent Payment as defined and described in the Statement.